Purification and structure elucidation of a cyclodipeptide from <i>Streptomyces cirratus</i> IHBB 10198 isolated from a glacier near Kunzum Pass in the Indian Trans-Himalayas

M. Pal; A. Kumari; S. Chhibber; A. Gulati

doi:10.15625/2525-2518/19970

Author affiliations

Authors

M. Pal \(^1\) CSIR-Institute of Himalayan Bioresource Technology, Palampur-176 061, India
\(^2\) Department of Biotechnology, Chandigarh College of Technology, Chandigarh Group of Colleges, Landran, Mohali-140307 (Punjab), India https://orcid.org/0000-0003-2823-0062
A. Kumari \(^1\) CSIR-Institute of Himalayan Bioresource Technology, Palampur-176 061, India
S. Chhibber \(^3\) Department of Microbiology, Panjab University, Chandigarh-160 014, India
A. Gulati \(^1\) CSIR-Institute of Himalayan Bioresource Technology, Palampur-176 061, India

DOI:

https://doi.org/10.15625/2525-2518/19970

Keywords:

Antimicrobial activity, Streptomyces, cyclodipeptide, glacier

Abstract

Streptomyces cirratus IHBB 10198 was isolated from a glacier in Lahaul-Spiti, located in Himachal Pradesh, India on yeast malt extract agar (YMEA). The isolate was identified as Streptomyces cirratus NRRL B-3250T based on 16S rRNA gene sequencing. Crude extract from the cell-free culture supernatant showed antibacterial activity against Gram-positive bacteria including Micrococcus luteus MTCC 2470, Bacillus subtilis MTCC 121, Staphylococcus aureus MTCC 96, Staphylococcus aureus MLS 16 MTCC 2940, Staphylococcus aureus MRSA ATCC 43300 and Gram-negative Klebsiella pneumoniae ATCC 43816. The crude extract also showed antibacterial activity against three out of thirty-three strains of Staphylococcus aureus from the clinical samples. The culture was subjected to twenty-five liters of large-volume culturing in tryptone soya broth (TSB). Cell-free supernatant was extracted twice with ethyl acetate, dried under vacuum, and then defatted. A cyclodipeptide, cyclo (L-Pro-L-Val) was purified from the culture crude extract by flash chromatography and preparative HPLC. Structure elucidation was done by mass spectrometry, FT-IR, and NMR. No antimicrobial activity was shown by purified cyclodipeptide like the crude extract. The lack of activity may be attributed to the presence of cis-trans conformers in the natural cyclodipeptide.

Downloads

Download data is not yet available.

References

1. Shapiro R. S., Zaas A. K., Betancourt-Quiroz M., Perfect J. R., Cowen L. E. - The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. PLoS One, 7(9) (2012) e44734. https://doi.org/10.1371/journal.pone.0044734.

2. Berdy J. - Bioactive microbial metabolites. J. Antibiot., 58(1) (2005) 1-26. https://doi.org/10.1038/ja.2005.1.

3. Lucas X., Senger C., Erxleben A., Gruning B. A., Doring K., Mosch J., Flemming S., Gunther S. - StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res., 41(Database issue) (2013) D1130-1136. https://doi.org/10.1093/nar/gks1253.

4. Pastrana-Camacho N., Suárez Z., Acosta-González A., Arango C., Haltli B., Correa H., Kerr R., Duque C., Díaz L. E. - Bioprospecting for culturable actinobacteria with antimicrobial properties isolated from rivers in Colombian Orinoquia. Trop. J. Pharm. Res., 15(6) (2016) 1259-1265. https://doi.org/10.4314/tjpr.v15i6.19.

5. Ahmed L., Rafik E., Mustapha B. - New Streptomyces barakatei strain, culture filtrate, derived active compounds and use thereof in the treatment of plants. (2009).

6. Napolitano A., Bruno I., Riccio R., Gomez-Paloma L. - Synthesis, structure, and biological aspects of cyclopeptides related to marine phakellistatins 7–9. Tetrahedron, 61(28) (2005) 6808-6815. https://doi.org/10.1016/j.tet.2005.04.067.

7. Reddy C. M., Pydah V. N. S. M., Mukkanti K., Acharyulu P. V. R. - Towards total synthesis of halolitoralin-C. Indian J. Chem. Sect. B, 46 (2007) 1137-1142.

8. Wipf P. - Synthetic Studies of Biologically Active Marine Cyclopeptides. Chem. Rev., 95(6) (2002) 2115-2134. https://doi.org/10.1021/cr00038a013.

9. Cavelier-Frontin F., Pepe G., Verducci J., Siri D., Jacquier R. - Prediction of the best linear precursor in the synthesis of cyclotetrapeptides by molecular mechanic calculations. J. Am. Chem. Soc., 114(23) (2002) 8885-8890. https://doi.org/10.1021/ja00049a021.

10. Rungprom W., Siwu E. R. O., Lambert L. K., Dechsakulwatana C., Barden M. C., Kokpol U., Blanchfield J. T., Kita M., Garson M. J. - Cyclic tetrapeptides from marine bacteria associated with the seaweed Diginea sp. and the sponge Halisarca ectofibrosa. Tetrahedron, 64(14) (2008) 3147-3152. https://doi.org/10.1016/j.tet.2008.01.089.

11. Smaoui S., Mellouli L., Lebrihi A., Coppel Y., Fguira L. F., Mathieu F. - Purification and structure elucidation of three naturally bioactive molecules from the new terrestrial Streptomyces sp. TN17 strain. Nat. Prod. Res., 25(8) (2011) 806-814. https://doi.org/10.1080/14786410902986225.

12. Aracil J. M., Badre A., Fadli M., Jeanty G., Banaigs B., Francisco C., Lafargue F., Heitz A., Aumelas A. - Nouveaux cyclotétrapeptides isolés de l'ascidie cystodytes delle chiajei. Tetrahedron Lett., 32(23) (1991) 2609-2612. https://doi.org/10.1016/s0040-4039(00)78797-1.

13. Kaur J., Singh P., Sharma D., Harjai K., Chhibber S. - A potent enzybiotic against methicillin-resistant Staphylococcus aureus. Virus Genes, 56(4) (2020) 480-497. https://doi.org/10.1007/s11262-020-01762-4.

14. Gulati A., Rahi P., Vyas P. - Characterization of phosphate-solubilizing fluorescent pseudomonads from the rhizosphere of seabuckthorn growing in the cold deserts of Himalayas. Curr. Microbiol., 56(1) (2008) 73-79. https://doi.org/10.1007/s00284-007-9042-3.

15. Kim O. S., Cho Y. J., Lee K., Yoon S. H., Kim M., Na H., Park S. C., Jeon Y. S., Lee J. H., Yi H., Won S., Chun J. - Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol., 62(Pt 3) (2012) 716-721. https://doi.org/10.1099/ijs.0.038075-0.

16. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. - MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol., 28(10) (2011) 2731-2739. https://doi.org/10.1093/molbev/msr121.

17. Sabitha G., Reddy D. V., Reddy S. S. S., Yadav J. S., Kumar C. G., Sujitha P. - Total synthesis of desacetylumuravumbolide, umuravumbolide and their biological evaluation. RSC Adv., 2(18) (2012) 7241-7247. https://doi.org/10.1039/c2ra20830j.

18. Sharma U., Katoch D., Sood S., Kumar N., Singh B., Thakur A., Gulati A. - ChemInform Abstract: Synthesis, Antibacterial and Antifungal Activity of 2‐Amino‐1,4‐naphthoquinones Using Silica‐Supported Perchloric Acid (HClO4—SiO2) as a Mild, Recyclable and Highly Efficient Heterogeneous Catalyst. ChemInform, 45(11) (2014) https://doi.org/10.1002/chin.201411101.

19. Chen H., Li Y., Wu J., Liu J., Huang Q., Wei S., Zhao G., Zhang Z., Hua L. - Purification and Identification of a novel antimicrobial protein from the rabbit sacculus rotundus and its effect on cellular immune function in mice. Int. J. Pept. Res. Ther., 21(4) (2015) 443-450. https://doi.org/10.1007/s10989-015-9472-x.

20. Taechowisan T., Chanaphat S., Ruensamran W., Phutdhawong W. S. - Antibacterial activity of new flavonoids from Streptomyces sp. BT01; an endophyte in Boesenbergia rotunda (L.) Mansf. J. Appl. Pharm. Sci., 4(4) (2014) 008-013. https://doi.org/10.7324/JAPS.2014.40402.

21. Nwodo U. U., Obiiyeke G. E., Chigor V. N., Okoh A. I. - Assessment of Tamarindus indica extracts for antibacterial activity. Int. J. Mol. Sci., 12(10) (2011) 6385-6396. https://doi.org/10.3390/ijms12106385.

22. Eijsink V. G. H., Skeie M., Middelhoven P. H., Brurberg M. B., Nes I. F. - Comparative Studies of Class IIa Bacteriocins of Lactic Acid Bacteria. Appl. Environ. Microbiol., 64(9) (1998) 3275-3281. https://doi.org/10.1128/AEM.64.9.3275-3281.1998.

23. Tabudravu J. N., Jaspars M., Morris L. A., Bosch J. J. K., Smith N. - Two distinct conformers of the cyclic heptapeptide Phakellistatin 2 isolated from the Fijian marine sponge Stylotella aurantium. J. Org. Chem., 67(24) (2002) 8593-8601. https://doi.org/10.1021/jo020482s.

24. Jing X., Jin K. - A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies. Med. Res. Rev., 40(2) (2020) 753-810. https://doi.org/10.1002/med.21639.

25. Jiang L., Huang P., Ren B. - Antibacterial polyene-polyol macrolides and cyclic peptides from the marine-derived Streptomyces sp. MS110128. Appl. Microbiol. Biotechnol., 105(12) (2021) 4975-4986. https://doi.org/10.1007/s00253-021-11226-w.

26. Wang C., Wu X., Bai H., Zaman K. A., Hou S., Saito J., Wongwiwatthananukit S., Kim K. S., Cao S. - Antibacterial and NF-κB inhibitory lumazine peptides, aspochalasin, γ-butyrolactone derivatives, and cyclic peptides from a Hawaiian Aspergillus flavipes. J. Nat. Prod., 83(7) (2020) 2233-2240. https://doi.org/10.1021/acs.jnatprod.0c00344.

27. Pérez-Bonilla M., Oves-Costales D., Gonzalez I., de la Cruz M., Martin J., Vicente F., Genilloud O., Reyes F. - Krisynomycins, imipenem potentiators against methicillin-resistant Staphylococcus aureus, produced by Streptomyces canus. J. Nat. Prod., 83(9) (2020) 2597-2606. https://doi.org/10.1021/acs.jnatprod.0c00294.